John Plevris at the 2020 Breath Biopsy Conference

The 2021 Breath Biopsy Conference is scheduled for 12th & 13th October. Click the button to express interest in the next Breath Biopsy Conference:

Express Interest

Talk Abstract:
Metabolic dysfunction in liver disease is reflected in the biocomposition of exhaled breath. Specific volatile organic compounds can be measured in breath samples and have diagnostic potential in chronic liver disease. For example alpha-terpinene, dimethyl sulfide, and D-limonene in exhaled breath can be used to stratify patients with non-alcoholic fatty liver disease. New technologies such as electronic nose systems or technology for rapid analysis of breath samples targeting specific volatile compounds show promise to non invasively stratify patients with liver disease, monitor patients most likely to progress and potentially diagnose of liver disease associated complications.

Speaker Biography:
John Plevris is professor and consultant in gastroenterology at the Royal Infirmary, University of Edinburgh. His research interests include liver cell biology, bioartificial liver support systems, in vitro models of NAFLD, endoscopic research and in particular research into non-invasive methods of investigating GI and liver disease such as wireless capsule endoscopy, transnasal endoscopy and breathomics technology for precision medicine and point of care diagnosis. He is an advanced therapeutic endoscopist with special interest in endoscopy in liver disease. He is also editor of two books
(Problem‐Based Approach to Gastroenterology and Hepatology 2012 and Endoscopy in Liver Disease 2017), recipient of several research grants and Clinical Educator – Director of Studies in year 2 at the Medical College of the University of Edinburgh.

The 2021 Breath Biopsy Conference is scheduled for 12th & 13th October. Click the button to express interest in the next Breath Biopsy Conference:

Express Interest